Iron Legion Virtus 30ml, Save when you order 2 or more with free shipping!
$44.95
Buy 2 or more for only 42.95 each with Free Shipping!!
Description
Free shipping on Iron Legion Virtus!
Buy 2 for only 42.95 each!
Stronger inhibition of estrogen than formestane, arimistane and aminogluthemide!
Virtus by Iron Legion is a topical application of the most powerful and versitile aromatase inhibitor ever released. Virtus was created with a sole purpose in mind; to effectively inhibit aromatase to provide a rapid decrease in estrogen levels. In effect, Virtus will prevent negative estrogenic side-effects associated with use of androgens, eliminate water-retention, increase free testosterone, and improve athletic performance. Give Iron Legion Virtus a try!!
- Stronger inhibition of estrogen than formestane, arimistane and aminogluthemide
- Increases natural testosterone leading to quicker gains
- Reduces inflammation in adipose tissue leading to fat loss
- Anti-Catabolic (prevents muscle loss)
- Improved libido and mood
- Increased strength
7-hydroxy-4-imidazolyl-flavan is a flavan derivative which is structurally similar to epicatechin, naringenin, and related compounds. Flavans such as this are naturally occurring in nature and commonly found in tea and chocolate.
Studies on Virtus’ active ingredient; 7-hydroxy-4-imidazolyl-flavan have demonstrated tremendous aromatase inhibitory potency at a staggering 127x more potent than aminogluthemide (prescription brand: Cytadren) and up to 10x more potent than the recently banned Formestane. In effect, Virtus by Iron Legion has rendered every other AI obsolete.
VirtusServing Size: 1 mL |
||
Amount Per Serving | ||
Serving | % DV | |
7-hydroxy-4-imidazolyl-flavan | 8 mg | – |
*percent Daily Values are based on a 2,000 calorie diet. | ||
Other Ingredients: Isopropyl alcohol, benzyl alcohol, propylene glycol, oleic acid, glycerin, thiazone, stearyl methacrylate, nerolidol, (+)-cedryl acetate, alpha-terpineol, fragrance (natural civetone and essential oils) |
Reviews
There are no reviews yet.